{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-031178","form_type":"8-K","ticker":"WINT","cik":"0000946486","company_name":"WINDTREE THERAPEUTICS INC /DE/","filed_at":"2025-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.693390+00:00","generated_at":"2026-05-17T03:40:20.012578+00:00","sec_items":["2.03","3.02","3.01","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Windtree Therapeutics issues $1.6M in senior convertible notes due 2026 with 10% interest and dilutive conversion terms","bullets":["Issued $1.6M aggregate principal in senior convertible promissory notes due Oct 9, 2026 to institutional investors.","Notes bear 10% per annum interest, payable monthly starting Nov 5, 2025; principal and accrued interest due at maturity.","Conversion price set at 90% of lowest sale price over 20 consecutive trading days prior to conversion; subject to automatic adjustment if conversion price < 80% of market price.","Notes junior to existing June 2025 senior convertible note held by DFU, LLC.","25% of gross proceeds from Common Stock Purchase Agreement must prepay notes at 120% premium; full prepayment required upon qualified equity financing of $1M+."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-031178","json":"https://secwatch.observer/filing/0001437749-25-031178.json","markdown":"https://secwatch.observer/filing/0001437749-25-031178.md","text":"https://secwatch.observer/filing/0001437749-25-031178.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946486/000143774925031178/0001437749-25-031178-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946486/000143774925031178/wint20251015_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:40:20.012578+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e361e4170fcdff9e2387a05b32920e55123ee82","claim":"WINDTREE THERAPEUTICS INC /DE/ incurred convertible notes of $1,600,000 with institutional investors at 10% per annum on a 360-day basis maturing October 9, 2026.","evidence_excerpt":"On October 9, 2025, Windtree Therapeutics, Inc. (the “Company”) issued to institutional investors (collectively, “Holders” and each a “Holder”) an aggregate principal amount of $1,600,000 in senior convertible promissory notes due 2026 (the “Commitment Notes”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/946486/000143774925031178/0001437749-25-031178-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$1,600,000"},{"label":"Counterparty","value":"institutional investors"},{"label":"Rate","value":"10% per annum on a 360-day basis"},{"label":"Maturity","value":"October 9, 2026"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}